Document:

Prepared by MerrillDirect

SECURITIES PURCHASE
AGREEMENT

                           This SECURITIES
PURCHASE AGREEMENT (“Agreement”), dated as of April 25, 2001, is by and between
Dental Advisors, a Nebraska corporation, ("Purchaser"), and Remedent
USA, Inc., a Nevada corporation (“Seller”) (collectively, the “Parties”).

W I T N E S S E T H

                           WHEREAS, Seller has
offered for sale to Purchaser units of its securities (the “Units”), each unit
consisting of one share of common stock (the “Shares”) and one warrant
exercisable at $0.25 for a term of five years (the “Warrants”), at a purchase
price of $0.25 per Unit (the “Purchase Price”).

                           WHEREAS, Seller
desires to sell to Purchaser and Purchaser desires to purchase from Seller,
Units upon the terms and conditions set forth herein.

                           NOW THEREFORE, in
consideration of the promises and respective mutual agreements herein
contained, it is agreed by and between the Parties hereto as follows:

ARTICLE 1

SALE AND PURCHASE OF THE UNITS

                           1.1        Sale of the Units.  Upon execution of this Agreement (the
"Closing"), subject to the terms and conditions herein set forth, and
on the basis of the representations, warranties and agreements herein
contained, SELLER shall sell to PURCHASER, and PURCHASER shall purchase from
SELLER, the Units.

                           1.2        Instruments of Conveyance and Transfer.  As soon as practicable after the Closing,
SELLER shall deliver a certificate or certificates representing the Units of
SELLER to PURCHASER sufficient to transfer all right, title and interest in the
Units to PURCHASER.

                           1.3        Consideration and Payment for the
Units.  In consideration for the
Units, PURCHASER shall pay a purchase price of a total of Three Hundred and
Thirteen Thousand dollars ($313,000.00) ($0.25 per Unit) (“Purchase Price”).

ARTICLE 2

REPRESENTATIONS AND COVENANTS OF SELLER AND PURCHASER

                           2.1        Seller hereby represents and warrants
that:

                                        (a)         This Agreement and the Units issuable
hereunder have been duly authorized by the appropriate corporate action of
Seller.

                                        (b)        Seller shall transfer title, in and to
the Units to Purchaser free and clear of all liens, security interests,
pledges, encumbrances, charges, restrictions, demands and claims, of any kind
and nature whatsoever, whether direct or indirect or contingent.

                                        (c)         As soon as practicable after each
Closing, Seller shall deliver to Purchaser a certificate or certificates
representing the Units subject to no liens, security interests, pledges,
encumbrances, charges, restrictions, demands or claims in any other party
whatsoever, except as set forth in the legend on the certificate, which legend
shall provide as follows:

THE SHARES (OR OTHER SECURITIES) REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933.  THE SHARES MAY NOT BE SOLD OR
TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL THAT
AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT IS AVAILABLE.

 

                                        (d)        Purchaser acknowledges that the Units
will be “restricted securities” (as such term is defined in Rule 144
promulgated under the Securities Act of 1933, as amended (“Rule 144"),
that the Units will include the foregoing restrictive legend, and, except as
otherwise set forth in this Agreement, that the Units cannot be sold unless
registered with the United States Securities and Exchange Commission (“SEC”)
and qualified by appropriate state securities regulators, or unless Purchaser
obtains written consent from Seller and otherwise complies with an exemption
from such registration and qualification (including, without limitation,
compliance with Rule 144).

                                        (e)         If the Company at any time proposes to
register any of its securities under the Act, except on a registration
statement on Form S-8 or Form S-4, the Company will use its best efforts to
cause the Shares, and the shares of common stock issuable upon exercise of the
Warrants (the “Warrant Shares”) owned by Holder to be registered under the Act
(with the securities which the Company at the time propose to register), all to
the extent requisite to permit the sale or other disposition by the Holder
(Piggyback Registration Rights); provided, however, that the Company may, as a
condition precedent to its effecting such registration, require the Holder to
agree with the Company and the managing underwriter or underwriters of the
offering to be made by the Company in connection with such registration that
the Holder will not sell any securities of the same class or convertible into
the same class as those registered by the Company (including any class into
which the securities registered by the Company are convertible) for such reasonable
period after such registration becomes effective as shall then be specified in
writing by such underwriter or underwriters if in the opinion of such
underwriter or underwriters the Company's offering would be materially
adversely affected in the absence of such an agreement (“underwriter’s
lock-up”).  Additionally, the managing
underwriter or underwriters of the offering to be made by the Company in
connection with such registration may require that Holder enter into an
agreement with the Company that only a percentage of the shares of common stock
underlying the Warrants owned by Holder be registered on such registration
statement if in the opinion of such underwriter or underwriters the Company's
offering would be materially adversely affected in the absence of such an
agreement (“underwriter’s carve-out”). 
All expenses incurred by the Company in complying with this Section,
including without limitation all registration and filing fees, listing fees,
printing expenses, fees and disbursements of all independent accounts, or
counsel for the Company and or counsel for the Holder and the expense of any
special audits incident to or required by any such registration and the
expenses of complying with the securities or blue sky laws of any jurisdiction
shall be paid by the Company. 
Notwithstanding the foregoing, Holder shall pay all underwriting
discounts or commissions with respect to any securities sold by the Holder.

                                                     (i)          In the event of any registration of
any of its securities under the Act pursuant to this Section, the Company
hereby indemnifies and holds harmless the Holder (which phrase shall include
any underwriters of such securities), their respective directors and officers,
and each other person who participates, in the offering of such securities and
each other person, if any, who controls the Holder, or such participating
persons within the meaning of the Act, against any losses, claims, damages or
liabilities, joint or several, to which each the Holder or any such director or
officer or participating person or controlling person may become subject under
the Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon any untrue
statement or alleged untrue statement of any material fact contained, on the
effective date thereof, in any registration statement under which such
securities were registered under the Act, any preliminary prospectus or final
prospectus contained therein, or any amendment or supplement thereto, or arise
out of or are based upon any omission or alleged omission to state therein an
material fact required to be stated therein or necessary to make the statements
therein not misleading; and will reimburse each the Holder and each director,
officer or participating or controlling person for any legal or any other
expenses reasonably incurred by the Holder or such director, officer or
participating or controlling person in connection with investigating or
defending any such loss, claim, damage, liability or action; provided, however,
that the Company shall not be liable in any such case to the extent that any
such loss, claim, damage or liability arises out of is based upon an untrue
statement or alleged untrue statement or omission or alleged omission made in
such registration statement, preliminary prospectus or prospectus or amendment
or supplement in reliance upon and in conformity with written information
furnished to the Company through an instrument duly executed by the Holder
specifically stating that it is for use therein.  Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Holder or such directors,
officer or participating or controlling person, and shall survive the transfer
of such securities by the Holder.

 

                                                     (ii)         The Holder shall by acceptance thereof,
indemnify and hold harmless the Company and its directors and officers, and
each person, if any who controls the Company, against any losses, claims,
damages or liabilities, joint or several, to which the Company or any director
or officer or any such person may become subject under the Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained, on the effective date thereof, in any
registration statement under which securities were registered under the Act at
the request of such holder, any preliminary prospectus or final prospectus
contained therein, or any amendment or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein
not misleading, in each case to the extent, but only to the extent, that such
untrue statement or alleged untrue statement or omission or alleged omission
was made in such registration statement, preliminary prospectus, prospectus,
amendment or supplement in reliance upon and in conformity with written
information furnished to the Company through an instrument duly executed by or
on behalf of such holder specifically stating that it is for use therein; and
will reimburse the Company or such director, officer or person for any legal or
any other expense reasonably incurred in connection with investigation or
defending any such loss, claim, damage, liability or action.

                                        (f)         If the Company shall be subject to the
reporting requirements of the Securities Exchange Act of 1934, as amended (the
"1934 Act"), the Company will use its best efforts timely to file all
reports required to be filed from time to time with the SEC (including but not
limited to the reports under Section 13 and 15(d) of the 1934 Act referred to in
subparagraph (c)(1) of Rule 144 adopted by the SEC under the Act).  If there is a public market for any
securities of the Company at any time that the Company is not subject to the
reporting requirements of either of said Section 13 or 15(d), the Company will,
upon the request of Holder, use its best efforts to make publicly available the
information concerning the Company referred to in subparagraph (c)(2) of said
Rule 144.  The Company will furnish to
Holder, promptly upon request, (i) a written statement of the Company's
compliance with the requirements of subparagraphs (c)(1) or (c)(2), as the case
may be, of said Rule 144, and (ii) written information concerning the Company
sufficient to enable Holder to complete any Form 144 required to be filed with
the SEC pursuant to said Rule 144.

                           2.2        Purchaser represents and warrants to
Seller as follows:

                                        (a)         Purchaser has adequate means of
providing for current needs and contingencies, has no need for liquidity in the
investment, and is able to bear the economic risk of an investment in the Units
offered by Seller of the size contemplated. 
Purchaser represents that Purchaser is able to bear the economic risk of
the investment and at the present time could afford a complete loss of such
investment.  Purchaser has had a full
opportunity to inspect the books and records of the Seller and to make any and
all inquiries of Seller officers and directors regarding the Seller and its
business as Purchaser has deemed appropriate.

                                        (b)        Purchaser is an “Accredited Investor” as
defined in Regulation D of the Securities Act of 1933 (the “Act”) or Purchaser,
either alone or with Purchaser’s professional advisers who are unaffiliated
with, have no equity interest in and are not compensated by Seller or any
affiliate or selling agent of Seller, directly or indirectly, has sufficient
knowledge and experience in financial and business matters that Purchaser is
capable of evaluating the merits and risks of an investment in the Units
offered by Seller and of making an informed investment decision with respect
thereto and has the capacity to protect Purchaser’s own interests in connection
with Purchaser’s proposed investment in the Units.

                                        (c)         Purchaser is acquiring the Units solely
for Purchaser’s own account as principal, for investment purposes only and not
with a view to the resale or distribution thereof, in whole or in part, and no
other person or entity has a direct or indirect beneficial interest in such
Units.

                                        (d)        Purchaser will not sell or otherwise
transfer the Units without registration under the Act or an exemption therefrom
and fully understands and agrees that Purchaser must bear the economic risk of
Purchaser’s purchase for an indefinite period of time because, among other
reasons, the Units have not been registered under the Act or under the
securities laws of any state and, therefore, cannot be resold, pledged,
assigned or other­wise disposed of unless they are subsequently registered
under the Act and under the applicable securities laws of such states or unless
an exemption from such registration is available.

ARTICLE 3

MISCELLANEOUS

                           3.1        Entire Agreement.  This Agreement sets forth the entire
agreement and understanding of the Parties hereto with respect to the
transactions contemplated hereby, and supersedes all prior agreements,
arrangements and understandings related to the subject matter hereof.  No understanding, promise, inducement,
statement of intention, representation, warranty, covenant or condition,
written or oral, express or implied, whether by statute or otherwise, has been
made by any party hereto which is not embodied in this Agreement or the written
statements, certificates, or other documents delivered pursuant hereto or in
connection with the transactions contemplated hereby, and no party hereto shall
be bound by or liable for any alleged understanding, promise, inducement,
statement, representation, warranty, covenant or condition not so set forth.

                           3.2        Notices.  Any notice, request, instruction, or other
document required by the terms of this Agreement, or deemed by any of the
Parties hereto to be desirable, to be given to any other party hereto shall be
in writing and shall be given by facsimile, personal delivery, overnight
delivery, or mailed by registered or certified mail, postage prepaid, with return
receipt requested, to the following addresses:

	To
  Purchaser:	Dental Advisors, Inc.
	

	314 North 4th Street
	 	Newman Grove, NE 68758
	 	Fax: (402) 447-6009
	 	Attn: Dr. Edward Quincy
	 	 
	To
  Seller:	Remedent USA, Inc.
	

	1220 Birch Way
	 	Escondido, CA 
  92027
	 	Fax: 
  (760) 781-3330
	 	Attn: Rebecca M. Inzunza, President
	 	 
	 	 
	With
  Copy To:	Senn Palumbo Meulemans, LLP
	

	18301 Von Karman, Suite 850
	 	Irvine, CA 
  92612
	 	Fax: (949) 251-1331
	 	Attn: Lynne Bolduc, Esq.
	 	 

The persons and
addresses set forth above may be changed from time to time by a notice sent as
aforesaid.  If notice is given by
facsimile, personal delivery, or overnight delivery in accordance with the
provisions of this Section, said notice shall be conclusively deemed given at
the time of such delivery.  If notice is
given by mail in accordance with the provisions of this Section, such notice
shall be conclusively deemed given seven days after deposit thereof in the
United States mail.

                           3.3        Waiver and Amendment.  Any term, provision, covenant,
representation, warranty or condition of this Agreement may be waived, but only
by a written instrument signed by the party entitled to the benefits
thereof.  The failure or delay of any
party at any time or times to require performance of any provision hereof or to
exercise its rights with respect to any provision hereof shall in no manner
operate as a waiver of or affect such party's right at a later time to enforce
the same.  No waiver by any party of any
condition, or of the breach of any term, provision, covenant, representation or
warranty contained in this Agreement, in any one or more instances, shall be
deemed to be or construed as a further or continuing waiver of any such
condition or breach or waiver of any other condition or of the breach of any
other term, provision, covenant, representation or warranty.  No modification or amendment of this
Agreement shall be valid and binding unless it be in writing and signed by all
Parties hereto.

                           3.4        Choice of Law.  This Agreement and the rights of the Parties
hereunder shall be governed by and construed in accordance with the laws of the
State of California including all matters of construction, validity,
performance, and enforcement and without giving effect to the principles of
conflict of laws.

                          3.5        Jurisdiction.  The Parties submit to the jurisdiction of
the Courts of the County of Orange, State of California or a Federal Court
empanelled in the State of California for the resolution of all legal disputes
arising under the terms of this Agreement, including, but not limited to,
enforcement of any arbitration award.

 

                           3.6        Counterparts.  This Agreement may be executed in one or
more counterparts, each of which shall be deemed an original, but all of which
shall together constitute one and the same instrument.

                           3.7        Attorneys' Fees.  Except as otherwise provided herein, if a
dispute should arise between the Parties including, but not limited to
arbitration, the prevailing party shall be reimbursed by the non-prevailing
party for all reasonable expenses incurred in resolving such dispute, including
reasonable attorneys' fees exclusive of such amount of attorneys' fees as shall
be a premium for result or for risk of loss under a contingency fee
arrangement.

                           3.8        Taxes.  Any income taxes required to be paid in connection with the
payments due hereunder, shall be borne by the party required to make such
payment.  Any withholding taxes in the
nature of a tax on income shall be deducted from payments due, and the party
required to withhold such tax shall furnish to the party receiving such payment
all documentation necessary to prove the proper amount to withhold of such
taxes and to prove payment to the tax authority of such required withholding.

                           IN WITNESS WHEREOF,
the Parties hereto have executed this Agreement, as of the date first written
hereinabove.

Seller

	Remedent USA, Inc.,	 
	a Nevada corporation	 
	 	 
	   /s/
  Rebecca M. Inzunza	 
	

	 
	By: Rebecca M. Inzunza	 
	Its: 
  President and CEO	 

 

Purchaser

	PLEASE CHECK ONE:	 	 
	 	 	 
	I.   If
  I am an individual, I certify that I am an "accredited investor"
  because:	 
	 	 	 
	 	   
  X      I had an individual income of more than $200,000 in each of the
  two most recent calendar years, and I reasonably expect to have an individual
  income in excess of $200,000 in the current calendar year; or my spouse and I
  had joint income in excess of $300,000 in each of the two most recent
  calendar years, and we reasonably expect to have a joint income in excess of
  $300,000 in the current calendar year.
	 	OR
	 	_______ I have an individual net worth, or my
  spouse and I have a joint net worth, in excess of $1,000,000 (including home
  and personal property).
				

II.          If PURCHASER is a corporation,
partnership, employee benefit plan or IRA, it certifies as follows:

A.         Has the subscribing entity been
formed for the specific purpose of investing in the Securities?

             o  
YES             ý   NO

If your answer
to question A is "No" CHECK whichever of the following statements (1–5)
is applicable to you.  If your answer to
question A is "Yes" the subscribing entity must be able to
certify to statement (B) below in
order to qualify as an "accredited investor".

             The undersigned entity certifies that it
is an "accredited investor" because it is:

1. _______ an employee benefit plan within
the meaning of Title I of the Employee Retirement Income Security Act of
1974, provided that the investment decision is made by a plan fiduciary, as
defined in section 3(21) of such Act, and the plan fiduciary is a bank,
savings and loan association, insurance company or registered investment
adviser; or

2. _______ an employee benefit plan within
the meaning of Title I of the Employee Retirement Income Security Act of
1974 that has total assets in excess of $5,000,000; or

3.___X___ each of its shareholders,
partners, or beneficiaries meets at least one of the following conditions
described above under INDIVIDUAL ACCREDITED INVESTOR STATUS. 
Please also CHECK the appropriate space in that section; or

4._______ the plan is a self directed
employee benefit plan and the investment decision is made solely by a person
that meets at least one of the conditions described above under INDIVIDUAL
ACCREDITED INVESTOR STATUS;
or

5._______ a corporation, a partnership or
a Massachusetts or similar business trust with total assets in excess of
$5,000,000.

B.         If the answer to Question A above
is "Yes," please certify the statement below is true and correct:

             _______
The undersigned entity certifies that it is an accredited investor because each
of its shareholder or beneficiaries meets at least one of the following
conditions described above under INDIVIDUAL ACCREDITED
INVESTOR STATUS.  Please also CHECK the appropriate space in
that section.

III.   If
PURCHASER is a Trust, it certifies as follows:

A.         Has the subscribing entity been formed
for the specific purpose of investing in the Securities?

                           o  
YES                                                                           
o  NO

If your answer
to question A is "No" CHECK whichever of the following
statements (1–3) is applicable to the subscribing entity.  If your answer to question A is
"Yes" the subscribing entity must be able to certify to the statement
(3) below in order to qualify as
an "accredited investor".

                
The undersigned trustee certifies that the trust is an "accredited
investor" because:

_______1)
the trust has total assets in excess of $5,000,000 and the investment decision
has been made by a "sophisticated person"; or

_______2)
the trustee making the investment decision on its behalf is a bank (as defined
in Section 3(a)(2) of the Act), a saving and loan association or other
institution as defined in Section 3(a)(5)(A) of the Securities Act, acting
in its fiduciary capacity; or

_______3)
the undersigned trustee certifies that the trust is an accredited investor
because the grantor(s) of the trust may revoke the trust at any time and regain
title to the trust assets and has (have) retained sole investment control over
the assets of the trust and the (each) grantor(s) meets at least one of the
following conditions described above under INDIVIDUAL ACCREDITED
INVESTOR STATUS.  Please also CHECK the appropriate space in
that section.

Print Name:        Dental Advisors, Inc.

    
/s/ Dr. Edward Quincy

             Dr. Edward Quincy

Address:  314 North 4th Street, Newman
Grove, NE 68758

Social Security/Tax I.D. Number : 
33-0962995

WARRANT AGREEMENT

                           This WARRANT
AGREEMENT (this "Agreement") is made and entered into as of April 25,
2001, between REMEDENT USA, INC., a Nevada corporation (the
"Company") and Dental Advisors, a Nebraska corporation
("Holder").

R E C
I T A L S

                           WHEREAS, the Company
proposes to issue to Holder 1,252,000 warrants (the "Warrants"), each
such Warrant entitling the holder thereof to purchase one share of Common Stock
of the Company (the "Exercise Shares," "Shares," or the
"Common Stock"); and

                           WHEREAS, the Warrants
which are the subject of this Agreement will be issued by the Company to Holder
as part of consideration payable to Holder in connection with an investment by
the Holder into the Company pursuant to a Securities Purchase Agreement on even
date herewith.

                           NOW, THEREFORE, in
consideration of the premises and the mutual agreements herein set forth, the
Parties hereto agree as follows:

A G R E E M E N T

 

                           1.          Warrant Certificates.  The warrant certificates to be delivered
pursuant to this Agreement (the "Warrant Certificates") shall be in
the form set forth in Exhibit A, attached hereto and made a part hereof, with
such appropriate insertions, omissions, substitutions and other variations as
are required or permitted by this Warrant Agreement.

                           2.          Right to Exercise Warrants.  Each Warrant may be exercised from the date
of this Agreement until 5:00 P.M. (Pacific time) on April 25, 2006 (the
"Expiration Date").

                           Each Warrant not
exercised on or before the Expiration Date shall expire.  Each Warrant shall entitle its holder to
purchase from the Company one share of Common Stock at an exercise price of
$0.25 per share, subject to adjustment as set forth below ("Exercise
Price").

                           The Company shall not
be required to issue fractional shares of capital stock upon the exercise of
this Warrant or to deliver Warrant Certificates, which evidence fractional
shares of capital stock.  In the event
that a fraction of an Exercise Share would, except for the provisions of this
paragraph 2, be issuable upon the exercise of this Warrant, the Company shall
pay to the Holder exercising the Warrant an amount in cash equal to such
fraction multiplied by the current market value of the Exercise Share.  For purposes of this Agreement, the current
market value shall be determined as follows:

                                        (a)         if the Exercise Shares are traded in
the over-the-counter market and not on any national securities exchange and not
in the NASDAQ Reporting System, the average of the mean between the last bid
and asked prices per share, as reported by the National Quotation Bureau, Inc.,
or an equivalent generally accepted reporting service, for the last business
day prior to the date on which this Warrant is exercised, or, if not so
reported, the average of the closing bid and asked prices for an Exercise Share
as furnished to the Company by any member of the National Association of
Securities Dealers, Inc., selected by the Company for that purpose.

                                        (b)        if the Exercise Shares are listed or
traded on a national securities exchange or in the NASDAQ Reporting System, the
closing price on the principal national securities exchange on which they are
so listed or traded or in the NASDAQ Reporting System, as the case may be, on
the last business day prior to the date of the exercise of this Warrant.  The closing price referred to in this Clause
(b) shall be the last reported sales price or, in case no such reported sale
takes place on such day, the average of the reported closing bid and asked prices,
in either case on the national securities exchange on which the Exercise Shares
are then listed or in the NASDAQ Reporting System; or

                                        (c)         if no such closing price or closing bid
and asked prices are available, as determined in any reasonable manner as may
be prescribed by the Board of Directors of the Company.

                           3.          Mutilated or Missing Warrant
Certificates.  In case any of the
Warrant Certificates shall be mutilated, lost, stolen or destroyed prior to its
expiration date, the Company shall issue and deliver, in exchange and substitution
for and upon cancellation of the mutilated Warrant Certificate, or in lieu of
and in substitution for the Warrant Certificate lost, stolen or destroyed, a
new Warrant Certificate of like tenor and representing an equivalent right or
interest.

                           4.          Reservation of Shares.  The Company will at all times reserve and
keep available, free from preemptive rights, out of the aggregate of its
authorized but unissued Shares or its authorized and issued Shares held in its
treasury for the purpose of enabling it to satisfy its obligation to issue
Shares upon exercise of Warrants, the full number of Shares deliverable upon
the exercise of all outstanding Warrants.

                           The Company covenants
that all Shares which may be issued upon exercise of Warrants will be validly
issued, fully paid and nonassessable outstanding Shares of the Company.

                           5.          Rights of Holder.  The Holder shall not, by virtue of anything
contained in this Warrant Agreement or otherwise, prior to exercise of this
Warrant, be entitled to any right whatsoever, either in law or equity, of a
stockholder of the Company, including without limitation, the right to receive
dividends or to vote or to consent or to receive notice as a shareholder in
respect of the meetings of shareholders or the election of directors of the
Company of any other matter.

                           6.          Investment Intent.  Holder represents and warrants to the
Company that Holder is acquiring the Warrants for investment and with no
present intention of distributing or reselling any of the Warrants.

                           7.          Certificates to Bear Language.  The Warrants and the certificate or
certificates therefor shall bear the following legend by which each holder
shall be bound:

"THE
WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE SHARES OF COMMON STOCK (OR
OTHER SECURITIES) ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933.  THE SHARES
MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR
TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF COUNSEL THAT
AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT IS AVAILABLE."

                           The Shares and the
certificate or certificates evidencing any such Shares shall bear the following
legend:

"THE
SHARES (OR OTHER SECURITIES) REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933. 
THE SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH
REGISTRATION OR AN OPINION OF COUNSEL THAT AN EXEMPTION FROM REGISTRATION UNDER
SUCH ACT IS AVAILABLE."

                           Certificates for
Warrants without such legend shall be issued if such warrants or shares are
sold pursuant to an effective registration statement under the Securities Act
of 1933 (the "Act") or if the Company has received an opinion from
counsel reasonably satisfactory to counsel for the Company, that such legend is
no longer required under the Act.

                           8.          Piggyback Registration Rights.  If the Company at any time proposes to
register any of its securities under the Act, except on a registration
statement on Form S-8 or Form S-4, the Company will use its best efforts to cause
all of the shares of common stock underlying the Warrants owned by Holder to be
registered under the Act (with the securities which the Company at the time
propose to register), all to the extent requisite to permit the sale or other
disposition by the Holder; provided, however, that the Company may, as a
condition precedent to its effecting such registration, require the Holder to
agree with the Company and the managing underwriter or underwriters of the
offering to be made by the Company in connection with such registration that
the Holder will not sell any securities of the same class or convertible into
the same class as those registered by the Company (including any class into
which the securities registered by the Company are convertible) for such reasonable
period after such registration becomes effective as shall then be specified in
writing by such underwriter or underwriters if in the opinion of such
underwriter or underwriters the Company's offering would be materially
adversely affected in the absence of such an agreement (“underwriter’s
lock-up”).  Additionally, the managing
underwriter or underwriters of the offering to be made by the Company in
connection with such registration may require that Holder enter into an
agreement with the Company that only a percentage of the shares of common stock
underlying the Warrants owned by Holder be registered on such registration
statement if in the opinion of such underwriter or underwriters the Company's
offering would be materially adversely affected in the absence of such an
agreement (“underwriter’s carve-out”). 
All expenses incurred by the Company in complying with this Section,
including without limitation all registration and filing fees, listing fees,
printing expenses, fees and disbursements of all independent accounts, or
counsel for the Company and or counsel for the Holder and the expense of any
special audits incident to or required by any such registration and the
expenses of complying with the securities or blue sky laws of any jurisdiction
shall be paid by the Company. 
Notwithstanding the foregoing, Holder shall pay all underwriting
discounts or commissions with respect to any securities sold by the Holder.

                                        (a)         Indemnification.

                                                     (i)          In the event of any registration of
any of its securities under the Act pursuant to this Section, the Company
hereby indemnifies and holds harmless the Holder (which phrase shall include
any underwriters of such securities), their respective directors and officers,
and each other person who participates, in the offering of such securities and
each other person, if any, who controls the Holder, or such participating
persons within the meaning of the Act, against any losses, claims, damages or
liabilities, joint or several, to which each the Holder or any such director or
officer or participating person or controlling person may become subject under
the Act or otherwise, insofar as such losses, claims, damages or liabilities
(or actions in respect thereof) arise out of or are based upon any untrue
statement or alleged untrue statement of any material fact contained, on the
effective date thereof, in any registration statement under which such
securities were registered under the Act, any preliminary prospectus or final
prospectus contained therein, or any amendment or supplement thereto, or arise
out of or are based upon any omission or alleged omission to state therein an
material fact required to be stated therein or necessary to make the statements
therein not misleading; and will reimburse each the Holder and each director,
officer or participating or controlling person for any legal or any other
expenses reasonably incurred by the Holder or such director, officer or
participating or controlling person in connection with investigating or
defending any such loss, claim, damage, liability or action; provided, however,
that the Company shall not be liable in any such case to the extent that any
such loss, claim, damage or liability arises out of is based upon an untrue
statement or alleged untrue statement or omission or alleged omission made in
such registration statement, preliminary prospectus or prospectus or amendment
or supplement in reliance upon and in conformity with written information
furnished to the Company through an instrument duly executed by the Holder
specifically stating that it is for use therein.  Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Holder or such directors,
officer or participating or controlling person, and shall survive the transfer
of such securities by the Holder.

                                                     (ii)         The Holder shall by acceptance thereof,
indemnify and hold harmless the Company and its directors and officers, and
each person, if any who controls the Company, against any losses, claims, damages
or liabilities, joint or several, to which the Company or any director or
officer or any such person may become subject under the Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon any untrue statement or alleged untrue
statement of any material fact contained, on the effective date thereof, in any
registration statement under which securities were registered under the Act at
the request of such holder, any preliminary prospectus or final prospectus
contained therein, or any amendment or supplement thereto, or arise out of or
are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein
not misleading, in each case to the extent, but only to the extent, that such
untrue statement or alleged untrue statement or omission or alleged omission
was made in such registration statement, preliminary prospectus, prospectus,
amendment or supplement in reliance upon and in conformity with written
information furnished to the Company through an instrument duly executed by or
on behalf of such holder specifically stating that it is for use therein; and
will reimburse the Company or such director, officer or person for any legal or
any other expense reasonably incurred in connection with investigation or
defending any such loss, claim, damage, liability or action.

                                        (b)        Rule 144.  If the Company shall be subject to the reporting requirements of the
Securities Exchange Act of 1934, as amended (the "1934 Act"), the
Company will use its best efforts timely to file all reports required to be
filed from time to time with the SEC (including but not limited to the reports
under Section 13 and 15(d) of the 1934 Act referred to in subparagraph (c)(1)
of Rule 144 adopted by the SEC under the Act). 
If there is a public market for any securities of the Company at any
time that the Company is not subject to the reporting requirements of either of
said Section 13 or 15(d), the Company will, upon the request of Holder, use its
best efforts to make publicly available the information concerning the Company
referred to in subparagraph (c)(2) of said Rule 144.  The Company will furnish to Holder, promptly upon request, (i) a
written statement of the Company's compliance with the requirements of
subparagraphs (c)(1) or (c)(2), as the case may be, of said Rule 144, and (ii)
written information concerning the Company sufficient to enable Holder to
complete any Form 144 required to be filed with the SEC pursuant to said Rule
144.

                           9.          Adjustment
of Number of Shares and Class of Capital Stock Purchasable.  The Number of Shares and Class of Capital
Stock purchasable under this Warrant Agreement are subject to adjustment from
time to time as set forth in this Section.

                                        (a)         Adjustment for Change in Capital
Stock.  If the Company:

                                                     (i)          pays a dividend or makes a
distribution on its Common Stock, in each case, in shares of its Common Stock;

                                                     (ii)         subdivides its outstanding shares of
Common Stock into a greater number of shares;

                                                     (iii)        combines its outstanding shares of
Common Stock into a smaller number of shares;

                                                     (iv)       makes a distribution on its Common Stock
in shares of its capital stock other than Common Stock; or

                                                     (v)        issues by reclassification of its shares
of Common Stock any shares of its capital stock;

then the number
and classes of shares purchasable upon exercise of each Warrant in effect
immediately prior to such action shall be adjusted so that the holder of any
Warrant thereafter exercised may receive the number and classes of shares of
capital stock of the Company which such holder would have owned immediately
following such action if such holder had exercised the Warrant immediately
prior to such action.

                           For a dividend or
distribution the adjustment shall become effective immediately after the record
date for the dividend or distribution. 
For a subdivision, combination or reclassification, the adjustment shall
become effective immediately after the effective date of the subdivision,
combination or reclassification.

                           If after an
adjustment the holder of a Warrant upon exercise of it may receive shares of
two or more classes of capital stock of the Company, the Board of Directors of
the Company shall in good faith determine the allocation of the adjusted
Exercise Price between or among the classes of capital stock.  After such allocation, that portion of the
Exercise Price applicable to each share of each such class of capital stock
shall thereafter be subject to adjustment on terms comparable to those
applicable to Common Stock in this Agreement. 
Notwithstanding the allocation of the Exercise Price between or among
shares of capital stock as provided by this Section 8(a), a Warrant may only be
exercised in full by payment of the entire Exercise Price currently in effect.

                                        b)          Consolidation, Merger or Sale of the
Company.  If the Company is a party to a
consolidation, merger or transfer of assets which reclassifies or changes its
outstanding Common Stock, the successor corporation (or corporation controlling
the successor corporation or the Company, as the case may be) shall by
operation of law assume the Company's obligations under this Warrant
Agreement.  Upon consummation of such
transaction the Warrants shall automatically become exercisable for the kind
and amount of securities, cash or other assets which the holder of a Warrant
would have owned immediately after the consolidation, merger or transfer if the
holder had exercised the Warrant immediately before the effective date of such
transaction.  As a condition to the
consummation of such transaction, the Company shall arrange for the person or
entity obligated to issue securities or deliver cash or other assets upon
exercise of the Warrant to, concurrently with the consummation of such
transaction, assume the Company's obligations hereunder by executing an
instrument so providing and further providing for adjustments which shall be as
nearly equivalent as may be practical to the adjustments provided for in this
Section 8.

 

                           10.        Successors.  All the covenants and provisions of this Agreement by or for the
benefit of the Company or Holder shall bind and inure to the benefit of their
respective successor and assigns hereunder.

                           11.        Counterparts.  This Agreement may be executed in any number of counterparts and
each of such counterparts shall for all proposes be deemed to be an original,
and such counterparts shall together constitute by one and the same instrument.

                           12.        Notices.  Any notice, request, instruction, or other document required by
the terms of this Agreement, or deemed by any of the parties hereto to be
desirable, to be given to any other party hereto shall be in writing and shall
be given by facsimile, personal delivery, overnight delivery, or mailed by
registered or certified mail, postage prepaid, with return receipt requested,
to the following addresses:

	To
  Purchaser:	Dental Advisors, Inc.
	

	314 North 4th Street
	 	Newman Grove, NE 68758
	 	Fax: (402) 447-6009
	 	Attn: Dr. Edward Quincy
	 	 
	To
  Seller:	Remedent USA, Inc.
	

	1220 Birch Way
	 	Escondido, CA 
  92027
	 	Fax: 
  (760) 781-3330
	 	Attn: Rebecca M. Inzunza, President
	 	 
	 	 
	With
  Copy To:	Senn Palumbo Meulemans, LLP
	

	18301 Von Karman, Suite 850
	 	Irvine, CA 
  92612
	 	Fax: (949) 251-1331
	 	Attn: Lynne Bolduc, Esq.
	 	 

A notice sent
as aforesaid may change the persons and addresses set forth above from time to
time.  If notice is given by facsimile,
personal delivery, or overnight delivery in accordance with the provisions of
this Section, said notice shall be conclusively deemed given at the time of
such delivery.  If notice is given by
mail in accordance with the provisions of this Section, such notice shall be
conclusively deemed given seven days after deposit thereof in the United States
mail.

                           13.        Supplements and Amendments.  The Company may from time to time supplement
or amend this Warrant Agreement without the approval of any Holders of Warrants
in order to cure any ambiguity or to be correct or supplement any provision
contained herein which may be defective or inconsistent with any other
provision, or to make any other provisions in regard to matters or questions
herein arising hereunder which the Company may deem necessary or desirable and
which shall not materially adversely affect the interest of the Holder.

                           14.        Severability.  If for any reason any provision, paragraph or term of this
Warrant Agreement is held to be invalid or unenforceable, all other valid
provisions herein shall remain in full force and effect and all terms,
provisions and paragraphs of this Warrant shall be deemed to be severable.

                           15.        Governing
Law and Venue.  This Warrant shall be
deemed to be a contract made under the laws of the State of California and for
all purposes shall be governed and construed in accordance with the laws of
said State.  Any proceeding arising
under this Warrant Agreement shall be instituted in the County of Orange, State
of California.

                           16.        Headings.  Paragraphs and subparagraph headings, used herein are included
herein for convenience of reference only and shall not affect the construction
of this Warrant Agreement nor constitute a part of this Warrant Agreement for
any other purpose.

                           IN WITNESS WHEREOF, the parties hereto have caused this
Agreement to be duly executed, as of the date and year first above written.

"COMPANY"

Remedent USA,
Inc.,

a Nevada corporation

     /s/ Rebecca M. Inzunza       

By:       Rebecca M. Inzunza

Its:        President and CEO

"HOLDER"

Dental Advisors
Inc.,

a Nebraska corporation

    /s/
Dr. Edward Quincy

By:       Dr. Edward Quincy

Its:        President

THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE 
SECURITIES ACT OF 1933 OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD,
EXCHANGED, HYPOTHECATED OR TRANSFERRED IN ANY MANNER EXCEPT PURSUANT TO A
REGISTRATION OR AN EXEMPTION FROM SUCH REGISTRATION AND IN COMPLIANCE WITH
SECTION 11 OF THE AGREEMENT PURSUANT TO WHICH THEY WERE ISSUED.

 Warrant
Certificate No. 5-25-01-01

WARRANTS TO PURCHASE 1,252,000 SHARES OF
COMMON STOCK

VOID AFTER 5:00 P.M.,

PACIFIC TIME, ON April 25, 2006

REMEDENT USA, INC.

INCORPORATED
UNDER THE LAWS

OF THE STATE OF NEVADA

                           This certifies that,
for value received, Dental Advisors, Inc, Nebraska, corporation, the registered
holder hereof or assigns (the "Warrantholder"), is entitled to
purchase from Remedent USA, Inc., a Nevada corporation (the
"Company"), at any time during the period commencing at 9:00 a.m.,
Pacific Time, on April 25, 2001, and before 5:00 p.m., Pacific Time, on April
25, 2001 at the purchase price per share of $0.25 (the "Warrant
Price"), the number of Shares of Common Stock of the Company set forth
above (the "Warrant Shares"). 
The number of Warrant Shares issuable upon exercise of each Warrant
evidenced hereby and the Warrant Price shall be subject to adjustment from time
to time as set forth in the Warrant Agreement referred to below.

                           The Warrants
evidenced hereby represent the right to purchase an aggregate of up to
1,252,000 Shares, subject to certain adjustments, and are issued under and in
accordance with a Warrant Agreement, dated as of April 25, 2001 (the "
Warrant Agreement"), between the Company and the Warrantholder in
connection with a Securities Purchase Agreement (the “Purchase Agreement”) and
are subject to the terms and provisions contained in the Warrant Agreement and
the Purchase Agreement, to all of which the Warrantholder by acceptance hereof
consents.

                           Holders of the
Warrants Shares issuable upon exercise hereof have certain rights with respect
to registration with the Securities and Exchange Commission of the Warrant
Shares.  These registration rights are
set forth in that certain Warrant Agreement of even date herewith pursuant to
which this Warrant Certificate has been issued.

                           The Warrants
evidenced hereby may be exercised in whole or in part by presentation of this
Warrant Certificate with the Purchase Form attached hereto duly executed (with
a signature guarantee as provided thereon) and simultaneous payment of the
Warrant Price at the principal office of the Company.  Payment of such price shall be made at the option of the
Warrantholder in cash, by check, or any combination thereof.

                           Upon any partial
exercise of the Warrants evidenced hereby, there shall be signed and issued to
the Warrantholder a new Warrant Certificate in respect of the Warrant Shares as
to which the Warrants evidenced hereby shall not have been exercised.  These Warrants may be exchanged at the
office of the Company by surrender of this Warrant Certificate properly
endorsed for one or more new Warrants of the same aggregate number of Warrant
Shares as evidenced by the Warrant or Warrants exchanged.  No fractional Shares of Common Stock will be
issued upon the exercise of rights to purchase hereunder, but the Company shall
pay the cash value of any fraction upon the exercise of one or more
Warrants.  These Warrants are
transferable at the office of the Company in the manner and subject to the
limitations set forth in the Warrant Agreement.

                           This Warrant
Certificate does not entitle any Warrantholder to any of the rights of a
stockholder of the Company unless and until the Warrantholder exercises its
rights to purchase Warrant Shares hereunder.

                                                                                REMEDENT
USA, INC.

	Dated: April 25, 2001	 	/s/ Rebecca M. Inzunza
	 	 	

	 	 	             By:
  Rebecca M. Inzunza
	 	 	             Its:
  President and CEO

REMEDENT USA, INC.

PURCHASE FORM

Remedent USA,
Inc.

1220 Birch Way

Escondido, CA  92027

                           The undersigned
hereby irrevocably elects to exercise the right of purchase represented by the
within Warrant Certificate for, and to purchase thereunder, ____________
Warrant Shares of Common Stock (the "Warrant Shares") provided for
therein, and requests that certificates for the Warrant Shares be issued in the
name of:

 

(Please Print or Type Name)

             

(Address, including zip code)

(Social Security No. or Tax I.D. No.)

and, if said
number of Warrant Shares shall not be all the Warrant Shares purchasable
hereunder, that a new Warrant Certificate for the balance of the Warrant Shares
purchasable under the within Warrant Certificate be registered in the name of
the undersigned Warrantholder or his Assignee as below indicated and delivered
to the address stated below.

	Name of Warrantholder	 	 	 	 	 
	or Assignee:	 	 	 	 	 
	 	

	 	(Please
  Print)	 
	Address:	 	 	 	 	 
	 	

	

	Signature:	 	 	 	Dated:	 
	 	

	 	

Note: 
The above signature must correspond with the name as written upon the
face of this Warrant Certificate in every particular, without alteration or
enlargement or any change whatever, unless these Warrants have been assigned.

 

	Signatures Guaranteed:	 
	 	

(Signature must
be guaranteed by a bank or trust company having an office or correspondent in
the United States or by a member firm of a registered securities exchange or
the National Association of Securities Dealers, Inc.)

ASSIGNMENT

(To be signed only upon assignment of Warrants)

             FOR VALUE RECEIVED, the undersigned
hereby sells, assigns and transfers unto the assignee named below all of the
rights of the undersigned represented by the attached Warrant with respect to
the number of Warrant Shares covered by the Warrant set forth below:

(Name and Address of Assignee Must Be Printed or
Typewritten)

 

	Name
  of Assignee	Social
  Security No.	Address	No.
  of
	 	or
  Tax ID No.	 	Warrant
  Shares
	 	 	 	 
	 	 	 	 
	

	and does hereby irrevocably constitute and
  appoint  	 
	 	

	Attorney to transfer said Warrants on the
  books of the Company, with full power of substitution in the premises.

 

	Dated:  	 	 	 
	 	

	 	

	 	 	 	Signature
  of Registered Holde

Note:    The signature on this assignment must
correspond with the name as it appears upon the face of the within Warrant
Certificate in every particular, without alteration or enlargement or any
change whatever.

	Signature Guaranteed:	 
	 	

(Signature must
be guaranteed by a bank or trust company having an office or correspondent in
the United States or by a member firm of a registered securities exchange or
the National Association of Securities Dealers, Inc.)

March 28, 2001

REMEDENT USA,
INC.

Attn:    Ms. Rebecca M. Inzunza,

             President / CEO

1220 Birch Way

Escondido, CA 92027

Re:       Retention of SENN PALUMBO MEULEMANS, LLP

             Subject:            General Business and Corporate Representation

Dear Ms.
Inzunza:

This
correspondence will serve to confirm that you have engaged our firm on an
hourly basis with regard to the above-referenced matters.  In general, our representation will include
a review and analysis of all information you provide in connection with the
above-referenced matter, an analysis of the materials, consultations, phone
conferences, preparation of pleadings and other documents, court appearances
and/or our recommendations in connection with the further handling of the
various matters.

We have found
that our clients appreciate having our billing 
procedures explained in writing. 
Experience has shown that the attorney–client relationship works
best when there is a mutual understanding about fees, costs and payment
terms.  Accordingly, we take this
opportunity to outline the terms on which we propose to provide our
professional services.

To help us
determine the value of our services, we ask each of our lawyers and legal
assistants to maintain time records for each client and matter.  The time records are reviewed monthly by the
billing attorney assigned to you before an invoice is rendered.  All of our services are billed at the hourly
rate then in effect for the attorney or legal assistant who is performing the
work. The attorneys and paralegals working on your matters will bill their time
at an hourly rate varying from $100.00 to $250.00, depending upon their
experience level and the complexity of the matter.

We will forward
our invoices on a monthly basis, and each invoice, unless otherwise specified,
represents our fees and out–of–pocket costs advanced for your
account through the end of the preceding month.  We make every effort to include disbursements in the statement
for the month in which the disbursements are incurred.  However, some disbursements, such as
telephone charges, are often not available to us until the following months, in
which case those disbursements will be included on a subsequent invoice.  Payment is due upon presentation of the
invoice, and invoices which remain unpaid after thirty days from the invoice
date are assigned a late payment charge of ten percent (10%) per annum.  In the unlikely event we are required to
incur legal or other costs to recover amounts due for fees and expenses on your
account, you will be responsible for those costs as well.

It is our
policy to serve you with the most effective support systems available, while at
the same time allocating the costs of such systems in accordance with the
extent of usage by individual clients. 
Therefore, in addition to our fees for legal services, we will also
invoice separately for certain costs and expense disbursements, including telephone,
facsimile, messenger, courier and other communication costs, reproduction,
document retrieval, staff overtime when required by the client or the matter's
timing, computer research facilities, document preparation on word processing,
and other costs and expenses incurred on your behalf.

It is our usual
and customary practice to require clients to remit a retainer to the firm for
each individual matter for which services are rendered. Based upon the nature
of our proposed engagement, our firm will require a retainer of 250,000 shares
for the first $20,000 in legal services. 
The 250,000 shares will be registered on Form S-8 immediately.  There will not be any lock-up on the 250,000
shares.  After the first $20,000 in
legal services, all services rendered will be billed at our regular hourly rates
and will paid on a cash basis.  All out
of pocket costs and expenses will be paid on a cash basis and are not included
in the initial $20,000 of legal services. 
Any estimates of anticipated fees that we provide at the request of the
client, whether for budgeting purposes or otherwise are, due to the
uncertainties involved, necessarily only an approximation of potential
fees.  Under no circumstances are such
estimates to be viewed as a maximum or minimum fee quotation.  Actual fees are always determined in
accordance with the policies described above.

Our firm
maintains errors and omissions insurance coverage which may be applicable to
the services to be rendered, subject to certain limitations and
exclusions.  If you have questions in
this regard, please feel free to call.

We hope this
adequately explains our fees and billing procedures.  We encourage you to discuss with us any questions you may have
regarding these policies and procedures, either at the inception of our
engagement or at any time during its course. 
If the terms set forth above are satisfactory, please sign and return
the enclosed copy of this letter and return it to us either by facsimile or
U.S. Mail.

We thank you
for selecting our firm for your legal representation and look forward to
working closely with you toward a speedy and successful resolution of this
matter.

Very truly
yours,

	  /s/
  Diane O. Palumbo	 	 
	

	 	 
	Diane O. Palumbo	 	 
	 	 	 
	APPROVED:	 	 
	 	 	 
	Dated: March 28, 2001	 	 
	

	 	 
	 	 	  
  /s/ Rebecca M. Inzunza
	 	 	

	 	 	Rebecca M. Inzunza, President
	 	 	REMEDENT USA, INC.

BUSINESS CONSULTING AGREEMENT

                           This Agreement (the
“Agreement”) is dated June 20, 2001 and is entered into by and between REMEDENT USA, INC.(hereinafter  “REMM” 
or “CLIENT”) and WINDSOR PARTNERS, INC. 
(hereinafter “WPI”).

             1.          Conditions.  This Agreement will not take effect, and WPI
will have no obligation to provide any service whatsoever, unless and until
CLIENT returns a signed copy of this Agreement to WPI (either by mail or
facsimile copy).  In addition, CLIENT shall
be truthful with WPI in regard to any relevant or material information provided
by CLIENT, verbally or otherwise which refers, relates, or otherwise pertains
to the CLIENT’s business, this Agreement or any other relevant transaction.
Breach of either of these conditions shall be considered a material breach and
will automatically grant WPI the right to terminate this Agreement and all
moneys, and other forms of compensation, paid or owing as of the date of
termination by WPI shall be forfeited without further notice.

                           Upon execution of
this Agreement, CLIENT agrees to fully cooperate with WPI in carrying out the
purposes of this Agreement, keep WPI informed of any developments of importance
pertaining to CLIENT’s business and abide by this Agreement in its entirety.

             2           Scope
and Duties.  During the term of this
Agreement, WPI will perform the following services for CLIENT:

                           2.1        Advice and Counsel.  WPI will provide advice and counsel
regarding CLIENT’s strategic business plans, strategy and negotiations with
potential business strategic partnering, corporate planning and or other
general business consulting needs as expressed by CLIENT.

                           2.2        Mergers and Acquisitions.  WPI will provide assistance to CLIENT, as
mutually agreed, in identifying merger and / or acquisition candidates,
assisting in any due diligence process, recommending transaction terms and
providing advice and assistance during negotiations, as needed.

                           2.3        CLIENT and/or CLIENT's Affiliate
Transaction Due Diligence.  WPI will
participate and assist CLIENT in the due diligence process, where possible, on
all proposed financial transactions affecting CLIENT of which WPI is notified
in writing in advance, including conducting investigation of and providing
advice on the financial, valuation and stock price implications of the proposed
transaction(s).

                           2.4        Ancillary Document Services.  If necessary, WPI will assist and cooperate
with CLIENT in the development, editing and production of such documents as are
reasonably necessary to assist in any transaction covered by this Agreement.
However, this Agreement will not include the preparation or procuring of legal
documents or those documents normally prepared by an attorney.

                           2.5        Additional Duties.  CLIENT and WPI shall mutually agree, in
writing, for any additional duties that WPI may provide to CLIENT for
compensation paid or payable by CLIENT under this Agreement.  Although there is no requirement to do so,
such additional agreement(s) may be attached hereto and made a part hereof by
written amendments to be listed as "Exhibits" beginning with
"Exhibit A" and initialed by both parties.

                           2.6        Standard of Performance. WPI
shall devote such time and efforts to the affairs of the CLIENT as is
reasonably necessary to render the services contemplated by this
Agreement.  Any work or task of WPI
provided for herein which requires CLIENT to provide certain information to
assist WPI in completion of the work shall be excused (without effect upon any
obligation of CLIENT) until such time as CLIENT has fully provided all
information and cooperation necessary for WPI to complete the work.  The services of WPI shall not include the
rendering of any legal opinions or the performance of any work that is in the
ordinary purview of a certified public accountant, or other licensed
professional.  WPI cannot guarantee
results on behalf of CLIENT, but shall use commercially reasonable efforts in
providing the services listed above.  If
an interest is communicated to WPI regarding satisfying all or part of CLIENT's
business and corporate strategic planning needs, WPI shall notify CLIENT and
advise it as to the source of such interest and any terms and conditions of
such interest.

                           2.7        Non-Guarantee.  WPI MAKES NO GUARANTEE THAT WPI WILL BE ABLE
TO SUCCESSFULLY LOCATE A MERGER OR ACQUISITION TARGET AND IN TURN CONSUMMATE A
MERGER OR ACQUISITION TRANSACTION FOR CLIENT, OR TO SUCCESSFULLY COMPLETE SUCH
A TRANSACTION WITHIN CLIENT’S DESIRED TIME FRAME. NEITHER ANYTHING IN THIS
AGREEMENT TO THE CONTRARY NOR THE PAYMENT OF DEPOSITS TO WPI BY CLIENT PURSUANT
TO FEE AGREEMENTS FOR SERVICES NOT CONTEMPLATED HEREIN SHALL BE CONSTRUED AS
ANY SUCH GUARANTEE.  ANY COMMENTS MADE
REGARDING POTENTIAL TIME FRAMES OR ANYTHING THAT PERTAINS TO THE OUTCOME OF
CLIENT'S NEEDS ARE EXPRESSIONS OF OPINION ONLY, AND FOR PURPOSES OF THIS
AGREEMENT ARE SPECIFICALLY DISAVOWED.

             3           Compensation
to WPI.

                           3.1        Issuance of Shares for Entering into
Agreement.  As consideration for WPI
entering into this Agreement, Client agrees to cause 300,000 shares of its
common stock, par value $.001 per share, to be issued in amounts of 150,000
shares to Richard Walker and     150,000
shares to Scott Absher , affiliates of WPI. When issued, said shares shall be
free trading shares, registered with the U.S. Securities and Exchange
Commission on its Form S-8 or similar registration.  The registration and issuance of said shares shall take place by
no later than 15 days following the execution and delivery of this Agreement,
and all costs in connection therewith shall be borne by Client.

             NOTE: WPI SHALL HAVE NO
OBLIGATION TO PERFORM ANY DUTIES PROVIDED FOR HEREIN IF PAYMENT [CASH AND/OR
STOCK] IS NOT RECEIVED BY WPI WITHIN 15 DAYS OF MUTUAL EXECUTION OF THIS
AGREEMENT BY THE PARTIES. IN ADDITION, WPI’S OBLIGATIONS UNDER THIS AGREEMENT
SHALL BE SUSPENDED IF ANY PAYMENT OWING HEREUNDER IS MORE THAN FIFTEEN (15)
DAYS DELINQUENT. FURTHERMORE, THE RECEIPT OF ANY FEES DUE TO WPI UPON EXECUTION
OF THIS AGREEMENT ARE NOT CONTINGENT UPON ANY PRIOR PERFORMANCE OF ANY DUTIES
WHATSOEVER DESCRIBED WITHIN THIS AGREEMENT.

                           3.2        Fees for Merger/Acquisition.  In the event that WPI, assists CLIENT and /
or introduces CLIENT (or a CLIENT affiliate) to any third party, merger
partner(s) or joint venture(s) who then enters into a merger, joint venture or
similar agreement with CLIENT or CLIENT's affiliate, CLIENT hereby agrees to
pay WPI advisory fees pursuant to the following schedule which are based on the
aggregate amount of such merger, joint venture or similar agreement with CLIENT
or CLIENT's affiliate. Advisory fees are deemed earned and shall be due and
payable at the first close of the transaction, however, in certain
circumstances when payment of advisory fees at closing is not possible, within
24 hours after CLIENT has received the proceeds of such business
combination.  This provision shall
survive this Agreement for a period of one year after termination or expiration
of this Agreement.  In other words, the
advisory fee shall be deemed earned and due and payable for any merger, joint venture
or similar transaction which first closes within a year of the termination or
expiration of this Agreement as a result of an introduction as set forth above.

                           3.3        Merger/Acquisition
Advisory Fees Schedule.  For a
merger/acquisition entered into by CLIENT as a result of the efforts of, or an
introduction by WPI during the term of this Agreement, Client shall pay WPI
Merger/Acquisition Advisory Fees as follows:

	•	For the first merger
  and/or acquisition of approximate annual revenue equal to or exceeding $35
  million, 2,200,000 shares of its common stock, 950,000 of which shall be free
  trading shares, registered with the U.S. Securities and Exchange Commission
  on its Form S-8 or similar registration. The remaining 1,250,000 shares shall
  be restricted subject to Rule 144.
	 	 
	•	When the annual revenue run rate for the
  aggregate of all  businesses WPI has
  assisted CLIENT and/or introduced CLIENT (or a CLIENT affiliate) to any third
  party, merger partner(s) or joint venture(s) who then entered into a merger,
  joint venture or similar agreement with CLIENT or CLIENT's affiliate, reaches
  fifty-five million ($55,000,000), 750,000 shares of its common stock, 375,000
  of which shall be free trading shares, registered with the U.S. Securities
  and Exchange Commission on its Form S-8 or similar registration. The
  remaining 375,000 shares shall be restricted subject to Rule 144.
	 	 
	•	Thereafter, for a merger/acquisition entered
  into by CLIENT as a result of the efforts of, or an introduction by WPI
  during the term of this Agreement, Client shall pay WPI, eight (8) percent of
  the total value of the transaction. For a merger/acquisition entered into by
  CLIENT as a result of the efforts of WPI and the introduction by CLIENT
  during the term of this Agreement, Client shall pay WPI, five (5) percent of
  the total value of the transaction. Such percentage(s) shall be paid to WPI
  in the same ratio of cash and / or stock as the transaction.

                           3.3        Expenses. After initial
acquisition, CLIENT shall reimburse WPI for reasonable expenses incurred in
performing its duties pursuant to this Agreement (including printing, postage,
express mail, photo reproduction, travel, lodging, and long distance telephone
and facsimile charges); provided, however, that WPI must receive prior written
approval from CLIENT for any expenses over $ 500.  Such reimbursement shall be payable within 7 seven days after
CLIENT's receipt of WPI invoice for same.

                           3.4        Additional
Fees.  CLIENT and WPI shall mutually
agree upon any additional fees that CLIENT may pay in the future for services
rendered by WPI under this Agreement. 
Such additional agreement(s) may, although there is no requirement to do
so, be attached hereto and made a part hereof as Exhibits beginning with Exhibit
A.

             4.          Indemnification.  The CLIENT agrees to indemnify and hold
harmless WPI, each of its officers, directors, employees, agents, and
shareholders against any and all liability, loss and costs, expenses or
damages, including but not limited to, any and all expenses whatsoever
reasonably incurred in investigating, preparing or defending against any
litigation, commenced or threatened, or any claim whatsoever or howsoever
caused by reason of any injury (whether to body, property, personal or business
character or reputation) sustained by any person or to any person or property,
arising out of any act, failure to act, neglect, any untrue or alleged untrue
statement of a material fact or failure to state a material fact which thereby
makes a statement false or misleading, or any breach of any material
representation, warranty or covenant by CLIENT or any of its agents, employees,
or other representatives.  WPI agrees to
indemnify and hold harmless the CLIENT, each of its officers, directors,
employees, agents, and shareholders against any and all liability, loss and
costs, expenses or damages, including but not limited to, any and all expenses
whatsoever reasonably incurred in investigating, preparing or defending against
any litigation, commenced or threatened, or any claim whatsoever or howsoever
caused by reason of any injury (whether to body, property, personal or business
character or reputation) sustained by any person or to any person or property,
arising out of any act, failure to act, neglect, any untrue or alleged untrue
statement of a material fact or failure to state a material fact which thereby
makes a statement false or misleading, or any breach of any material
representation, warranty or covenant by WPI or any of its agents, employees, or
other representatives.  Nothing herein
is intended to nor shall it relieve either party from liability for its own
willful act, omission or negligence. 
All remedies provided by law, or in equity shall be cumulative and not
in the alternative.

             5.          Confidentiality.

                           5.1        WPI
and CLIENT each agree to keep confidential and provide reasonable security
measures to keep confidential information where release may be detrimental to
their respective business interests. 
WPI and CLIENT shall each require their employees, agents, affiliates,
other licensees, and others who will have access to the information through WPI
and CLIENT respectively, to first enter appropriate non-disclosure Agreements
requiring the confidentiality contemplated by this Agreement in perpetuity.

                           5.2        WPI will not, either during its engagement
by the CLIENT pursuant to this Agreement or at any time thereafter, disclose,
use or make known for its or another's benefit any confidential information,
knowledge, or data of the CLIENT or any of its affiliates in any way acquired
or used by WPI during its engagement by the CLIENT.  Confidential information, knowledge or data of the CLIENT and its
affiliates shall not include any information that is, or becomes generally
available to the public other than as a result of a disclosure by WPI or its representatives.

             6           Miscellaneous Provisions.

                           6.1        Amendment and Modification.  This Agreement may be amended, modified and
supplemented only by written agreement of WPI and CLIENT.

                           6.2        Assignment.  This Agreement and all of the provisions
hereof shall be binding upon and inure to the benefit of the parties hereto and
their respective successors and permitted assigns. The obligations of either
party hereunder cannot be assigned without the express written consent of the
other party.

                           6.3        Governing Law; Venue.  This Agreement and the legal relations among
the parties hereto shall be governed by and construed in accordance with the
laws of the State of California, without regard to its conflict of law
doctrine.  CLIENT and WPI agree that if
any action is instituted to enforce or interpret any provision of this
Agreement, the jurisdiction and venue shall be Orange County, California.

                           6.4        Attorneys' Fees and Costs.  If any action is necessary to
enforce and collect upon the terms of this Agreement, the prevailing party
shall be entitled to reasonable attorneys’ fees and costs, in addition to any
other relief to which that party may be entitled. This provision shall be
construed as applicable to the entire Agreement.

                           6.5        Survivability.   If any part of this Agreement is found, or
deemed by a court of competent jurisdiction, to be invalid or unenforceable,
that part shall be severable from the remainder of the Agreement.

                           6.6        Counterparts.  This Agreement may be executed in several
counterparts and it shall not be necessary for each party to execute each of
such counterparts, but when all of the parties have executed and delivered one
of such counterparts, the counterparts, when taken together, shall be deemed to
constitute one and the same instrument, enforceable against each party in
accordance with its terms.

                           6.7        Facsimile Signatures.  The Parties hereto agree that this Agreement
may be executed by facsimile signatures and such signatures shall be deemed
originals.  The parties further agree
that within ten days following the execution of this Agreement, they shall
exchange original signature pages.

             7.          ARBITRATION. ALL DISPUTES,
CONTROVERSIES, OR DIFFERENCES BETWEEN CLIENT, WPI OR ANY OF THEIR OFFICERS,
DIRECTORS, LEGAL REPRESENTATIVES, ATTORNEYS, ACCOUNTANTS, AGENTS OR EMPLOYEES,
OR ANY CUSTOMER OR OTHER PERSON OR ENTITY, ARISING OUT OF, IN CONNECTION WITH
OR AS A RESULT OF THIS AGREEMENT, SHALL BE RESOLVED THROUGH ARBITRATION RATHER
THAN THROUGH LITIGATION.  WITH RESPECT
TO THE ARBITRATION OF ANY DISPUTE, THE UNDERSIGNED HEREBY ACKNOWLEDGE AND AGREE
THAT:

                           A.         ARBITRATION IS FINAL AND BINDING ON THE PARTIES;

                           B.          THE PARTIES ARE WAIVING THEIR RIGHT TO
SEEK REMEDY IN COURT, INCLUDING THEIR RIGHT TO JURY TRIAL;

                           C.          RE-ARBITRATION DISCOVERY IS GENERALLY
MORE LIMITED AND DIFFERENT FROM COURT PROCEEDING;

                           D.         THE ARBITRATOR’S AWARD IS NOT REQUIRED
TO INCLUDE FACTUAL FINDINGS OR LEGAL REASONING AND ANY PARTY'S RIGHT OF APPEAL
OR TO SEEK MODIFICATION OF RULING BY THE ARBITRATORS IS STRICTLY LIMITED;

                           E.          THIS ARBITRATION PROVISION IS
SPECIFICALLY INTENDED TO INCLUDE ANY AND ALL STATUTORY CLAIMS WHICH MIGHT BE
ASSERTED BY ANY PARTY;

                           F.          EACH PARTY HEREBY AGREES TO SUBMIT THE
DISPUTE FOR RESOLUTION TO THE AMERICAN ARBITRATION ASSOCIATION, IN ORANGE
COUNTY, CALIFORNIA WITHIN FIVE (5) DAYS AFTER RECEIVING A WRITTEN REQUEST TO DO
SO FROM THE OTHER PARTY;

 

                           G.          IF EITHER PARTY FAILS TO SUBMIT THE
DISPUTE TO ARBITRATION ON REQUEST, THEN THE REQUESTING PARTY MAY COMMENCE AN
ARBITRATION PROCEEDING, BUT IS UNDER NO OBLIGATION TO DO SO;

                           H.         ANY HEARING SCHEDULED AFTER AN
ARBITRATION IS INITIATED SHALL TAKE PLACE IN ORANGE COUNTY, CALIFORNIA;

                           I.           IF EITHER PARTY SHALL INSTITUTE ANY
COURT PROCEEDING IN AN EFFORT TO RESIST ARBITRATION AND BE UNSUCCESSFUL IN
RESISTING ARBITRATION OR SHALL UNSUCCESSFULLY CONTEST THE JURISDICTION OF ANY
ARBITRATION FORUM LOCATED IN ORANGE COUNTY, CALIFORNIA, OVER ANY MATTER WHICH
IS THE SUBJECT OF THIS AGREEMENT, THE PREVAILING PARTY SHALL BE ENTITLED TO
RECOVER FROM THE LOSING PARTY ITS LEGAL FEES AND ANY OUT-OF-POCKET EXPENSES
INCURRED IN CONNECTION WITH THE DEFENSE OF SUCH LEGAL PROCEEDING OR ITS EFFORTS
TO ENFORCE ITS RIGHTS TO ARBITRATION AS PROVIDED FOR HEREIN;

                           J.           THE PARTIES SHALL ACCEPT THE DECISION
OF ANY AWARD AS BEING FINAL AND CONCLUSIVE AND AGREE TO ABIDE THEREBY;

                           K.         ANY DECISION MAY BE FILED WITH ANY
COURT AS A BASIS FOR JUDGMENT AND EXECUTION FOR COLLECTION.

             8.          Term/Termination.  This Agreement is an agreement for the term
of approximately twenty-four (24) 
months ending June 30, 2003.

             9.          Non Circumvention.  In and
for valuable consideration, CLIENT hereby agrees that WPI may introduce
(whether by written, oral, data, or other form of communication) CLIENT to one
or more opportunities, including, without limitation, natural persons,
corporations, limited liability companies, partnerships, unincorporated
businesses, sole proprietorships and similar entities (hereinafter an
“Opportunity” or ““Opportunities””). 
CLIENT further acknowledges and agrees that the identity of the subject
Opportunities, and all other information concerning an Opportunity (including
without limitation, all mailing information, phone and fax numbers, email
addresses and other contact information) introduced hereunder are the property
of WPI, and shall be treated as confidential and proprietary information by
CLIENT, it affiliates, officers, directors, shareholders, employees, agents,
representatives, successors and assigns. 
CLIENT shall not use such information, except in the context of any
arrangement with WPI in which WPI is directly and actively involved, and never
without WPI's prior written approval. 
CLIENT further agrees that neither it nor its employees, affiliates or
assigns, shall enter into, or otherwise arrange (either for it/him/herself, or
any other person or entity) any business relationship, contact any person
regarding such Opportunity, either directly or indirectly, or any of its
affiliates, or accept any compensation or advantage in relation to such
Opportunity except as directly though WPI, without the prior written approval
of WPI.  WPI is relying on CLIENT’s
assent to these terms and their intent to be bound by the terms by evidence of
their signature.  Without CLIENT’s
signed assent to these terms, WPI would not introduce any Opportunity or
disclose any confidential information to CLIENT as herein described.

[SIGNATURES FOLLOW NEXT PAGE]

             IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed, all as of the day and year
first above written.

REMEDENT USA,
INC. (REMM)

	Print Name:	Rebecca Inzunza/Hegemann	 
	 	

	 
	Sign Name: 	/s/ Rebecca Inzunza/Hegemann	 
	 	

	 
	Title:	CEO	 
	 	

	 
	Date:	June 28, 2001	 
	 	

	 
	Address:	1220 Birch Way	 
	 	

	 
	 	             Escondido,
  CA 92007	 
	 	

	 

 

WINDSOR
PARTNERS, INC. ( WPI)

 

	Print Name:	Richard H. Walker	 	 
	 	

	 	 
	Sign Name:	/s/ Richard H. Walker	 	 
	 	

	 	 
	Title:	President	 	 
	 	

	 	 
	 	 	 	 
	Date:	June 28, 2001	 	 
	 	

	 	 
	Address:	28202 Cabot Road, Suite 300	 	 
	 	

	 	 
	 	Laguna Niguel, CA 92677Prepared by MerrillDirect

 

	CLASS A COMMON SHARES	CLASS A COMMON SHARES
	 	 
	

	 	 
	 	 
	THIS
  CERTIFIES THAT	See  reverse for certain definitions
	 	CUSIP
  74372Y  10  0

 

is the owner of

             FULLY PAID AND NON-ASSESSABLE CLASS A COMMON SHARES OF THE PAR VALUE OF
ONE CENT ($.01) EACH OF

	

	 PROVELL,
  INC. 	

 transferable on the books of the Corporation by the holder
hereof  in person or by duly authorized
attorney upon surrender of this  certificate
properly endorsed.This certificate is not valid  unless countersigned by the TransferAgent and Registrar.

             WITNESS
the facsimile signatures of its duly authorized officers.

Dated:

 

	 	/s/ Samia Haddad	 	/s/ George S. Richards
	 	SECRETARY	 	CHAIRMAN

 

	COUNTERSIGNED AND REGISTERED:
WELLS FARGO BANK MINNESOTA, N.A.
(MINNEAPOLIS,
  MINNESOTA) TRANSFER AGENT AND REGISTRAR
	 
	BY	 
	 	AUTHORIZED SIGNATURE

 

The Corporation
will furnish to any shareholder, without charge, upon request made in writing,
a full statement of the designations, preferences, limitations and relative
rights of the shares of each class authorized to be issued.

              The following abbreviations, when
used in the inscription on the face of this certificate, shall be construed as
though they were written out in full according to applicable laws or
regulations:

 

	TEN
  COM	—	as
  tenants in common	 	UNIF
  GIFT MIN ACT	—	_____________

  (Cust)	Custodian	_____________

  (Minor)
	TEN
  ENT	—	as
  tenants by the entireties	 	 	 	under
  Uniform Transfers to Minors
	JT
  TEN	—
  	as
  joint tenants with right of survivorship and not as tenants in common	 	 	 	Act	__________

  (State)	 

Additional abbreviations may also be used though
not in the above list.

For value received ____ hereby sell, assign and transfer
unto

	PLEASE
  INSERT SOCIAL SECURITY OR OTHER

  IDENTIFYING NUMBER OF ASSIGNEE	 
	

	

	PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS OF
  ASSIGNEE
	

	

	

_____________________________________________  Shares of the capital stock represented by
the within Certificate, and do hereby irrevocably constitute and appoint

_____________________________________________ 
Attorney to transfer the said stock on the books of the within-named
Corporation with full power of substitution in the premises.

	Dated 	 	

	 	 	

	 	 	NOTICE:
  THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN
  UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR
  ENLARGEMENT OR ANY CHANGE WHATEVER.

SIGNATURE
GUARANTEED BY

This certificate also evidences and entitles the holder
hereof to certain rights as set forth in a Rights Agreement between Provell,
Inc. and Wells Fargo Bank Minnesota, N.A., dated as of April 16, 1998 (the
"Rights Agreement"), the terms of which (including restrictions on
the transfer of such Rights) are hereby incorporated herein by reference and a
copy of which is on file at the principal executive offices of Provell, Inc.
Under certain circumstances, as set forth in the Rights Agreement, such Rights
will be evidenced by separate certificates and will no longer be evidenced by
this certificate. Provell, Inc. will mail to the holder of this certificate a
copy of the Rights Agreement without charge after receipt of a written request
therefor. Under certain circumstances, as set forth in the Rights Agreement,
Rights that are or were issued to any Person who becomes an Acquiring Person,
or any Affilliate or Associate thereof (as such terms are defined in the Rights
Agreement), whether currently held by or on behalf of such Person or by any
subsequent holder thereof, may become null and void.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00028-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00028-of-00352.parquet"}]]